Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
HD-CAR-1 - Heidelberg University Hospital
Tecartus (brexucabtagene autoleucel) - Gilead
Epkinly (epcoritamab-bysp) - Genmab, AbbVie
Yescarta (axicabtagene ciloleucel) - Gilead
Columvi (glofitamab-gxbm) - Roche
Lunsumio (mosunetuzumab-axgb) - Roche
https://www.sciencedirect.com/science/article/abs/pii/S2152265026026686
 
Büsranur Yilmaz MD 1,2; Alina Tariq MD 3; Tamara Hossein 4; Ioana-Elena Tarabasanu-Mihaila MD 5; Silvia Halteh 6; Fatmanur Yilmaz MD 7; Bailey Grones 8
 
Sep 1, 2026
 
Prev Next